HomeNDC LookupIngredientsLoratadine › 72888-0029-11
LORATADINE 10 mg Tablet, Orally Disintegrating — NDC 72888-0029-11 package photo

LORATADINE 10 mg Tablet, Orally Disintegrating

by Advagen Pharma Limited · 3 BLISTER PACK in 1 CARTON (72888-029-11) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
NDC 72888-0029-11
🏷️ FDA NDC (as labeled) 72888-029-11 billing pads the product segment with a zero
This package
Contains10 tablet, orally disintegrating in 1 blister pack Cost per ea$0.5326 NADAC Per package$15.98 / 30 tablets Pack sizes2 compare ↓
Also priced by: Medicaid pays $0.7930/unit — full pricing hub ↓
Also comes in: 10 tablets 72888-0029-09
OTC Generic On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

🆔 Identity & classification

FDA NDC (as labeled) 72888-029-11
Product NDC 72888-029
11-digit billing NDC 72888002911
NCPDP billing unit EA — each (per item)
RxCUI 311373
UNII 7AJO3BO7QN
UPC 0372888029115
Application # ANDA214280
SPL Set ID a5699a95-c0a7-43ea-9bab-bbfaba3c8aa5
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2020-09-10
Route ORAL
Dosage form TABLET, ORALLY DISINTEGRATING
Substance LORATADINE
GPI-14 41550030007220
GCN Seq No 030476
GCN 60521
HICL code 007605
Ingredient (HICL) Loratadine
HIC1 code Z
Therapeutic class — broad (HIC1) Body As A Whole
HIC2 code Z2
Therapeutic class — intermediate (HIC2) Antihistamines, Antiserotonins, Immunosuppressants
HIC3 code Z2Q
Therapeutic class — specific (HIC3) Antihistamines - 2Nd Generation
AHFS code 04:08.00.00
AHFS class Second Generation Antihistamines
FDB label name LORATADINE 10 MG ODT
FDB brand name Loratadine
Legend status O — Over-the-counter (OTC) drug or device
Why two NDCs? The FDA registers this code as 72888-029-11 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 72888-0029-11. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Other antihistamines for systemic use class.

Drug family (ATC) Other antihistamines for systemic use
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerAdvagen Pharma Limited
Application holderRUBICON RESEARCH LTD
FDA applicationANDA214280 (ANDA)
Labeler code72888
First marketedSep 2020
Product typeHuman Otc Drug
Portfolio78 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

Label name LORATADINE 10 MG ODT Ingredient Loratadine
📖 What it is MedlinePlus · NLM

Loratadine is used to treat allergy symptoms: sneezing runny nose itching of the nose or throat red, itchy, or watery eyes Loratadine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • Loratadine is an antihistamine that temporarily relieves common allergy symptoms — things like a runny nose, sneezing, itchy or watery eyes, and an itchy nose or throat. It works f...
  • When taken as directed, loratadine is considered non-drowsy for most people. However, if you take more than the recommended daily amount, drowsiness can happen. So stick to the dos...
  • It depends on the age. Children 6 and older can take standard adult doses of most forms. Children 2 to under 6 can use the oral solution or chewable tablets, but at a lower amount....
  • You should check with your doctor before taking loratadine if you have liver or kidney disease. Your doctor may need to adjust your dose. It's not necessarily off-limits, but it's...
📖 Read our full Loratadine guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color white
ShapeRound
ImprintUpArrowhead43
Size1 mm
ScoringNot scored
FlavorPeppermint
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII Z0H242BBR1
    Aspartame is an artificial sweetener made from amino acids. It's added to medicines to improve taste, making bitter or unpleasant-tasting drugs easier to take.
  • UNII 2S7830E561
    Crospovidone is a synthetic polymer derived from povidone. It acts as a disintegrant, helping the tablet or capsule break apart quickly in the stomach so the active ingredient can be absorbed.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII 3OWL53L36A
    A natural sugar alcohol derived from seaweed or synthesized in the lab. It's used as a filler to add bulk, a sweetener in sugar-free formulas, and a disintegrant to help tablets break apart in the stomach.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII 7CV7WJK4UI
    Sodium stearyl fumarate is a synthetic compound made from stearyl alcohol and fumaric acid. It acts as a lubricant and glidant in tablets and capsules, helping ingredients flow smoothly during manufacturing and preventing sticking.
  • UNII O8232NY3SJ
    A plant-based carbohydrate derived from corn kernels. It acts as a filler to add bulk, a binder to hold ingredients together, and a disintegrant to help the tablet break apart in your stomach for absorption.

8 inactive ingredients listed in the exact product block matched to this NDC.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMedingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.533 $15.98 / 30 tablets
Medicaid paysCMS SDUD · 12 mo $0.7930 $23.79 / 30 tablets
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Dec 2023 Jan 2026 Apr 2026 Aug 2026 $0.597 $0.354
▲ Up 50% over the last 11 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Loratadine ODT 10 mg 00536-1367-07 Rugby 10 tablets $0.533 Availability likely
Loratadine ODT 10 mg 46122-0539-52 Amerisource 10 tablets $0.533 Availability likely
Loratadine 10 mgthis 72888-0029-11 Advagen 10 tablets $0.533 Availability likely
good sense allergy relief 10 mg 00113-1191-65 L. 1 tablet FDA listed
good sense allergy relief 10 mg 00113-9755-65 L. 1 tablet FDA listed
Childrens Loratadine Odt 10 mg 00363-4020-84 WALGREEN 10 tablets FDA listed
Loratadine ODT 10 mg 00363-9937-84 WALGREEN 10 tablets FDA listed
Claritin Reditabs 10 mg 11523-4329-01 Bayer 10 tablets FDA listed
Claritin Reditabs 10 mg 11523-7157-02 Bayer 10 tablets FDA listed
loratadine 10 mg 11822-0558-00 Rite 1 tablet FDA listed
loratadine 10 mg 11822-0919-00 Rite 1 tablet Discontinued
Loratadine ODT 10 mg 21130-0221-84 Better 10 tablets FDA listed
signature care allergy relief 10 mg 21130-0301-65 Safeway 1 tablet Discontinued
signature care allergy relief 10 mg 21130-0452-65 Safeway 1 tablet FDA listed
allergy relief 10 mg 30142-0446-65 Kroger 1 tablet FDA listed
Topcare Allergy Relief 10 mg 36800-0853-65 Topco 1 tablet FDA listed
non drowsy allergy relief 10 mg 41250-0890-65 Meijer 1 tablet FDA listed
careone allergy relief 10 mg 41520-0510-65 American 1 tablet FDA listed
Loratadine 10 mg 43598-0707-30 Dr. 10 tablets FDA listed
Loratadine 10 mg 43598-0758-10 Dr. 10 tablets FDA listed
Loratadine ODT 10 mg 49035-0806-03 Wal-Mart 10 tablets FDA listed
Loratadine 10 mg 51316-0503-01 CVS 10 tablets FDA listed
Allergy Relief 10 mg 51316-0931-46 CVS 1 tablet FDA listed
Allergy Relief 10 mg 51660-0527-31 Ohm 1 tablet FDA listed
Loratadine ODT 10 mg 53943-0035-03 DISCOUNT 10 tablets FDA listed
dg health allergy relief 10 mg 55910-0594-46 Dolgencorp, 1 tablet FDA listed
dg health allergy relief 10 mg 55910-0970-46 Dolgencorp, 1 tablet FDA listed
Allervarx 10 mg 57483-0950-10 Innovus 10 tablets FDA listed
Loratadine ODT 10 mg 58602-0744-83 Aurohealth 10 tablets FDA listed
Loratadine ODT 10 mg 58602-0821-83 Aurohealth 10 tablets FDA listed
Loratadine ODT 10 mg 58602-0830-83 Aurohealth 10 tablets FDA listed
Loratadine ODT 10 mg 58602-0881-15 Aurohealth 10 tablets FDA listed
Loratadine 10 mg 59556-0917-01 Strides 10 tablets FDA listed
Loratadine ODT 10 mg 60000-0950-83 Ahold 10 tablets FDA listed
Loratadine ODT 10 mg 68016-0088-10 Chain 10 tablets FDA listed
Alavert Allergy 10 mg 69536-0190-60 Foundation 1 tablet FDA listed
Alavert Allergy 10 mg 69536-0195-20 Foundation 1 tablet FDA listed
Loratadine ODT 10 mg 69842-0085-03 CVS 10 tablets FDA listed
Basic Care Allergy Relief 10 mg 72288-0200-65 Amazon.com 1 tablet FDA listed
Basic Care Allergy Relief 10 mg 72288-0451-65 Amazon.com 1 tablet FDA listed
Loratadine 10 mg 72983-0501-01 Tenshi 10 tablets FDA listed
Loratadine 10 mg 72983-0503-06 Tenshi 1 tablet FDA listed
equate loratadine 10 mg 79903-0381-10 WALMART 1 tablet FDA listed
Alavert Allergy 10 mg 80070-0110-18 Foundation 1 tablet FDA listed
Alavert Allergy 10 mg 80070-0120-60 Foundation 1 tablet FDA listed
Allergy Relief 10 mg 79481-9723-01 Meijer, 1 tablet FDA listed
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2020
On the market since
Sep 2020
📍
2026
Currently FDA-listed
6 years listed
🔓
·
Generic on the market
this product is a generic
This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🗺️ Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 72888-0029-11, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
4.6K
Units reimbursed last 4 qtrs
139.4K
Gross reimbursed last 4 qtrs
$110.5K
Avg / prescription
$24.00
Avg / unit
$0.7930
Latest quarter Q4 2025
522Rx
Medicaid pays / ea
$0.7930
gross reimbursed
vs
NADAC / ea
$0.5326
acquisition cost
=
Spread
+$0.2604
+49% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care
39% FFS 61% MCO
Fee-for-service · 1,797 Rx Managed care · 2,809 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 5,192 units · 90.5 per 100k residents MN Wisconsin: no data reported WI Michigan: 3,910 units · 39.0 per 100k residents MI New York: no data reported NY Vermont: no data reported VT New Hampshire: 944 units · 67.3 per 100k residents NH Oregon: 3,772 units · 89.1 per 100k residents OR Nevada: 1,245 units · 39.0 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: 750 units · 6.0 per 100k residents IL Indiana: 6,854 units · 99.9 per 100k residents IN Ohio: 17,049 units · 145 per 100k residents OH Pennsylvania: 11,772 units · 90.8 per 100k residents PA New Jersey: 4,458 units · 48.0 per 100k residents NJ Massachusetts: no data reported MA California: 45,759 units · 117 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: 630 units · 10.2 per 100k residents MO Kentucky: 5,066 units · 112 per 100k residents KY West Virginia: 430 units · 24.3 per 100k residents WV Virginia: 2,662 units · 30.5 per 100k residents VA Maryland: 7,304 units · 118 per 100k residents MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: 6,264 units · 84.3 per 100k residents AZ New Mexico: 885 units · 41.9 per 100k residents NM Kansas: no data reported KS Arkansas: 758 units · 24.7 per 100k residents AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: 870 units · 16.2 per 100k residents SC Delaware: 420 units · 40.7 per 100k residents DE Oklahoma: no data reported OK Louisiana: 684 units · 15.0 per 100k residents LA Mississippi: no data reported MS Alabama: 751 units · 14.7 per 100k residents AL Georgia: 6,339 units · 57.5 per 100k residents GA D.C.: no data reported DC Hawaii: 2,400 units · 167 per 100k residents HI Texas: 2,223 units · 7.3 per 100k residents TX Florida: no data reported FL
Units reimbursed · per 100k residents
6.0167
gray = no data reported
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Hawaii 167 /100k
2 Ohio 145 /100k
3 Maryland 118 /100k
4 California 117 /100k
5 Kentucky 112 /100k
6 Indiana 99.9 /100k
7 Pennsylvania 90.8 /100k
8 Minnesota 90.5 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

💊 Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
10 tablets72888-0029-09 4,732 Rx · $114,691
10 tablets this page72888-0029-11 4,606 Rx · $110,536
Drug total (last 4 qtrs): 9,338 Rx · 266,654 units · $225,227 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for LORATADINE — the ingredient across all brands.

Top reported reactions

Fatigue6,880
Nausea6,108
Headache5,618
Dyspnoea5,027
Diarrhoea4,995
Dizziness4,683
Pain4,258

Age at onset

Neonate39
Infant137
Child2,951
Adolescent762
Adult13,205
Elderly8,007

Reporter sex

114,197 reports
Male · 33%
Female · 66%
Unknown · 0%

Serious outcomes

Hospitalization23,691
Death4,744
Life-threatening2,561
Disabling2,302
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 8,335 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startStatus
72888-0029-09 1 BLISTER PACK in 1 CARTON (72888-029-09) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK $0.5326 / ea $5.33 2020-09-10 Active
72888-0029-11 You're viewing this 3 BLISTER PACK in 1 CARTON (72888-029-11) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK $0.5326 / ea $15.98 2020-09-10 Active

This pack effectively ties for the lowest per-ea cost of the 2 priced pack sizes ($0.5326 NADAC).

This pack accounts for about 49% of this product's recent Medicaid fills; most go to a different pack size. See all packs ↓

Pack size FAQ

What quantity is in NDC 72888-0029-11?
NDC 72888-0029-11 is listed by the FDA — 3 blister pack in 1 carton / 10 tablet, orally disintegrating in 1 blister pack.
What NDC number is used to bill for this package of LORATADINE 10 mg Tablet, Orally Disintegrating?
Bill NDC 72888-0029-11 — the 11-digit billing format is 72888002911. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🧪 Active Ingredient ~1 min read

Drug Facts Active ingredient (in each tablet) Purpose Loratadine USP, 10 mg………………………………….....................Antihistamine Uses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: ■ runny nose ■ itchy, watery eyes ■ sneezing ■ itching of the nose or throat Warnings Do not use if you have ever had an allergic reaction to this product or any of its ingredients. Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose.

When using a product do not take more than directed. Taking more than directed may cause drowsiness. Stop use and ask a doctor if an allergic reaction to this product occurs.

Seek medical help right away. If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away. Directions place 1 tablet on tongue; tablet disintegrates, with or without water adults and children 6 years and over 1 tablet daily; not more than 1 tablet in 24 hours Children under 6 years of age ask a doctor Consumers with liver or kidney disease ask a doctor Other information Phenylketonurics: contains phenylalanine (a component of aspartame) 1.52 mg per 10 mg orally disintegrating tablet. safety sealed: do not use if the individual blister unit imprinted with Loratadine Orally Disintegrating Tablets USP 10 mg is open or torn store between 20° to 25°C (68° to 77°F) use tablet immediately after opening individual blister FDA approved acceptance criteria for assay and organic impurities differs from USP test Inactive ingredients aspartame, colloidal silicon dioxide, crospovidone, magnesium stearate, maize starch, mannitol, microcrystalline cellulose, peppermint flavor, sodium stearyl fumarate Questions or comments?

Advagen - 866-488-0312 Distributed by: Advagen Pharma Ltd East Windsor, NJ 08520, USA Manufactured by: Rubicon Research Ltd., Thane 421506, India. Rev. 02, 11/24

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.